BCLP Advises Alticor in Sale of Metagenics to Gryphon
International law firm Bryan Cave Leighton Paisner has advised Alticor in its sale of Metagenics, a leading global nutritional supplement company, to Gryphon Investors, a private equity firm focused on profitability growing and competitively enhancing middle-market companies in partnership with experienced management.
The value of this transaction, which closed Nov. 1, remains confidential.
Alticor was advised by a BCLP cross-practice deal team from offices in the US and Paris, led by Partner Bob Newmark (Corporate Transactions). Others of key support included Seth Frederiksen (Corporate Transactions), Caitlin Hartsell (Corporate Transactions), Danielle Hennessey (Corporate Transactions) and Zack Carpenter (Corporate Transactions), Becky Nelson (Antitrust), Danielle Mangogna (Antitrust), Jessica Edwards (Tax), Amy de La Lama (Data Privacy), Bart Wall (Finance Transactions), Adam Braun (EBEC).
Click here to read the full press release issued by Gryphon Investors on this transaction.
This document provides a general summary and is for information/educational purposes only. It is not intended to be comprehensive, nor does it constitute legal advice. Specific legal advice should always be sought before taking or refraining from taking any action.